Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Ampacet's AI system automatically corrects color variations in real time, improving quality and reducing waste in operations.
Zacks Investment Research on MSN
FLGT to acquire Bako & StrataDx assets to expand pathology platform
Fulgent Genetics, Inc. FLGT recently entered into an agreement to acquire selected assets of Bako Diagnostics and to acquire ...
EFS Plastics calls for stronger policies and collaboration to boost post-consumer resin adoption amid low virgin plastic ...
Approaches incorporating rapid or digital PCR, CRISPR, syndromic testing, and multimodal systems reached new milestones this year.
That’s the aim of predictive cyber resilience (PCR)—an emerging approach to security built on intelligence, automation and ...
Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...
Asianet Newsable on MSN
Jammu IGP Bhim Sen Tuti reviews ERSS-112 preparedness and roadmap
IGP Jammu Bhim Sen Tuti reviewed the ERSS-112 implementation roadmap, focusing on the ERSS-2.0 rollout. The goal is to reduce ...
The world of medical testing is always changing, and point-of-care molecular diagnostics are a big part of that. These tests let us find out what’s going on with a patient’s health right there, ...
The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This ...
A landmark study, titled “How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier datasets of short reads” recently published in ...
At this year’s ELRIG Drug Discovery meeting, Technology Networks sat down with Dr. Robert Beal, a field application specialist at Bio-Rad, to discuss how advances in digital polymerase chain reaction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results